Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants

  1. Luke T. Krebs1,
  2. John R. Shutter2,
  3. Kenji Tanigaki3,
  4. Tasuku Honjo3,
  5. Kevin L. Stark2, and
  6. Thomas Gridley1,4
  1. 1The Jackson Laboratory, Bar Harbor, Maine 04609, USA; 2Department of Metabolic Disorders, Amgen, Inc., Thousand Oaks, California 91320, USA; 3Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan

Abstract

The Notch signaling pathway is essential for embryonic vascular development in vertebrates. Here we show that mouse embryos heterozygous for a targeted mutation in the gene encoding the DLL4 ligand exhibit haploinsufficient lethality because of defects in vascular remodeling. We also describe vascular defects in embryos homozygous for a mutation in the Rbpsuh gene, which encodes the primary transcriptional mediator of Notch signaling. Conditional inactivation of Rpbsuh function demonstrates that Notch activation is essential in the endothelial cell lineage. Notch pathway mutant embryos exhibit defects in arterial specification of nascent blood vessels and develop arteriovenous malformations. These results demonstrate that vascular remodeling in the mouse embryo is sensitive to Dll4 gene dosage and that Notch activation in endothelial cells is essential for embryonic vascular remodeling.

Keywords

Footnotes

  • Supplemental material is available at http://www.genesdev.org.

  • Article published online ahead of print. Article and publication date are at http://www.genesdev.org/cgi/doi/10.1101/gad.1239204.

  • 4 Corresponding author. E-MAIL gridley{at}jax.org; FAX (207) 288-6077

    • Accepted August 11, 2004.
    • Received July 12, 2004.
| Table of Contents

Life Science Alliance